Stockholders' Deficit (Tables)

12 Months Ended

Dec. 31, 2020

Stockholders' Deficit (Tables) [Line Items]

Schedule of Stock by Class [Table Text Block]

The shares of Series X Preferred stock were issued as follows:

	Type of			Share		Liability
Name	Liability	# shares		Value		Amount			Loss
Ronald Riewold, Director	Deferred Compensation		1,200	$	41,675	$	30,000		$	(11,675	)
Larry Diamond, Director and CEO	Deferred Compensation		2,000	$	69,458	$	50,000		$	(19,458	)
Julie R. Smith, Director, COO and President (c) (now ex-Officer and Director)	Deferred Compensation		2,000	$	69,458	$	50,000		$	(19,458	)
James Crone, ex-Officer and Director	Deferred Compensation		2,884	$	100,158	$	72,089		$	(28,069	)
Louis Deluca, ex-Officer and Director	Deferred Compensation		2,400	$	83,350	$	60,000		$	(23,350	)
Irish Italian Retirement Fund	Consulting services, notes payable (a)		12,503	$	434,216	$	312,572	(a)	$	(121,644	)
Frank Lightmas	Legal fees		3,240	$	112,522	$	81,000	(b)	$	(31,522	)
Total			26,227	$	910,837	$	655,661		$	(255,176	)

(a) Amount consists of accounts payable for consulting services of $174,813, and principal plus interest due on notes payable in the amount of $137,759.

(b) Amount consists of $71,279 in legal fees due and $9,721 in prepaid legal fees.

(c) Ms. Smith resigned effective July 1, 2020.

Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]

The following table summarizes the options outstanding at December 31, 2020 and the related prices for the options to purchase shares of the Company’s common stock:

						Weighted				Weighted
				Weighted		average				average
				average		exercise				exercise
Range of		Number of		remaining		price of		Number of		price of
exercise		options		contractual		outstanding		options		exercisable
prices		outstanding		life (years)		options		exercisable		options
$	0.03		13,453,879		9.42	$	0.03		11,303,879	$	0.03
			13,453,879		9.42	$	0.03		11,303,879	$	0.03

Share-based Payment Arrangement, Option, Activity [Table Text Block]

Transactions involving stock options are summarized as follows:

	Shares			Weighted- Average Exercise Price ($) (A)
Outstanding at December 31, 2018		67,879		$	0.03
Granted		-			-
Cancelled		-			-
Outstanding at December 31, 2019		67,879		$	0.03
Granted		14,886,000		$	0.03
Cancelled		(1,500,000	)		0.03
Outstanding at December 31, 2020		13,453,879		$	0.03
Exercisable at December 31, 2020 (B)		11,303,879		$	0.03

(A) On December 14, 2020, the Company reset the exercise price of all the options then outstanding options to $0.03 per share. This included 150,000 options previously priced at $0.04 per share; 7,450,000 options previously priced at $0.05 per share; 1,000,000 options previously priced at $0.06 per share; and 67,879 options previously prices at $21.40 per share. The Company valued these options as of December 14, 2020, at the original exercise price and at the new price of $0.03 per share and charged the increase in value in the amount of $4,113 to operations during the year ended December 31, 2020. The exercise prices of all options are shown at the restated price of $0.03 per share.

(B) On December 28, 2020, the Company accelerated the vesting of certain of its options issued to Board members, management, and consultants, resulting in a charge to operations in the amount of $164,647 during the year ended December 31, 2020.

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

The Company valued stock options during the years ended December 31, 2020 and 2019 using the Black-Scholes valuation model utilizing the following variables:

	December 31,			December 31,
	2020			2019
Volatility		149.4% to 209.6	%		228.0% to 229.4	%
Dividends	$	-		$	-
Risk-free interest rates		0.55% to 1.30	%		1.75% to 2.53	%
Term (years)		5.00			5.00

Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

The following table summarizes the warrants outstanding at December 30, 2020 and the related prices for the warrants to purchase shares of the Company’s common stock:

	Shares			Weighted- Average Exercise Price ($)
Outstanding at December 31, 2018		1,167,653		$	2.18
Granted		400,000		$	0.00858
Additional warrants due to trigger of ratchet feature		6,659,382		$	0.00858
Exercised – cashless conversion		(3,514,900	)	$	0.00858
Forfeited		(2,769,482	)	$	0.00858
Expired		(142,653	)		17.42
Outstanding at December 31, 2019		1,800,000		$	0.00858
Granted		6,582,382		$	0.00858
Exercised		(8,382,382	)	$	0.0561
Outstanding at December 31, 2020		-		$	-

Series X Preferred Stock [Member]

Stockholders' Deficit (Tables) [Line Items]

Schedule of Stock by Class [Table Text Block]

The shares of Series X Preferred stock were issued as follows:

	Type of			Share		Liability
Name	Liability	# shares		Value		Amount			Loss
Ronald Riewold, Director	Deferred Compensation		1,200	$	41,675	$	30,000		$	(11,675	)
Larry Diamond, Director and CEO	Deferred Compensation		2,000	$	69,458	$	50,000		$	(19,458	)
Julie R. Smith, Director and President (now ex-Officer and Director)	Deferred Compensation		2,000	$	69,458	$	50,000		$	(19,458	)
James Crone, ex-Officer and Director	Deferred Compensation		2,884	$	100,158	$	72,089		$	(28,069	)
Louis Deluca, ex-Officer and Director	Deferred Compensation		2,400	$	83,350	$	60,000		$	(23,350	)
Irish Italian Retirement Fund	Consulting services, notes payable (a)		12,503	$	434,216	$	312,572	(a)	$	(121,644	)
Frank Lightmas	Legal fees		3,240	$	112,522	$	81,000	(b)	$	(31,522	)
Total			26,227	$	910,837	$	655,661		$	(255,176	)